Takeda.
company in Rome, Italy
- Reports this week
- 2
- Active events
- 0
- Connections
- 27
What's happening
Earlier this month
One to three months ago
-
Takeda and Protagonist Therapeutics secured global co-development rights and received FDA approval for a drug treating rare blood cancer.Some support1 report
-
Takeda announced FDA approval of its drug MIMRYLO, a decision supported by VERIFY results.Some support3 reports
-
India approved Takeda's dengue vaccine.Some support11 reports
-
Insilico Medicine and Takeda announced a strategic collaboration to advance drug candidates.Some support4 reports
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Takeda this week
News at the entities that move Takeda most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Takeda
-
Tokyo Stock Exchange StructuralMediciNova, Inc. listed its company on the Tokyo Stock Exchange on September 28, 2026.Moves Takeda
Connections
The 9 strongest of 27, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Julie Kim Structural
Julie Kim was appointed President and CEO of Takeda, establishing an ongoing executive leadership role.
-
Tokyo Stock Exchange Structural
Takeda is a company whose shares are listed and actively traded on the Tokyo Stock Exchange.
-
Christophe Weber Structural
Christophe Weber served as the chief executive officer of Takeda before retiring from the company and board.
-
FDA Structural
The FDA formally regulates Takeda's pharmaceutical products, granting approvals and accepting new drug applications.
-
Insilico Medicine Operational
Insilico Medicine and Takeda are engaged in a strategic partnership focused on leveraging AI platforms to co-develop drug candidates.
-
Novavax Structural
Takeda provides financial support to Novavax through royalty payments, boosting its market outlook.
-
KROS Operational
The two companies are engaged in an ongoing global development partnership where Takeda leads the clinical trial milestones and payments.
-
Verify Operational
Verify provided results supporting Takeda's MIMRYLO regulatory approval.
Show all 9 connections
-
NIP Mentioned together
Evidence suggests Takeda is seeking inclusion in a public health program, but NIP's involvement is not mentioned.